Dustin Sellers of Koa Capital Partners explains the middle-market investment opportunity in the Aloha State.

RSM’s Dave Noonan explains one area of focus in his firm’s Rough Order of Magnitude due diligence service, designed to help private equity clients quickly predict the costs of a carve-out transaction during the critical pre-deal phase.

Townsend Group’s Prashant Tewari says investing in real estate in Asian countries requires a deep understanding of the continent’s differing economies.

Toll Brothers’ U.S. CFO, Marty Connor, expects an extended RE cycle for residential for-sale homes, and says the firm is hedging its bets expanding into condo and multifamily development.

Experts from Cambridge Associates, Coller Capital, and Guardian Life explain why co-investments are increasingly popular, how they are performing, and how to be aware of adverse selection.

Experts from Cambridge Associates, Coller Capital, and Guardian Life discuss GPs needing capital for “outside the strike zone” deals, and how LPs need to carefully track whether a co-investment opportunity is within the strike zone of a GP.

Experts from Cambridge Associates, Coller Capital, and Guardian Life discuss why there is more variation in fee structures than ever before.

Experts from Cambridge Associates, Coller Capital, and Guardian Life discuss why distributions to LPs are at record-high levels.

Experts from Cambridge Associates, Coller Capital, and Guardian Life discuss the impact of LP dry powder earmarked for co-investments that’s not included in most PE fundraising data.

GE Capital’s divestiture of its commercial lending unit, Antares, to CPPIB creates questions about its future, says Golub Capital’s Lawrence Golub.

NewWorld Capital’s Lou Schick explains the investment in SolarEdge and its exit via a successful IPO in March 2015.

What one pharma executive thinks about the Daraprim drug pricing controversy.